Cline Christopher R.

Insider profile

Performance

Overall performance
2.8

Performance over holding periods
2.8
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 66% 68% 82%
Transactions
20 0% Buy
34 71% Buy
47 69% Buy
Cline Christopher R.'s trades of Travere Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-06 2026-05-06 PlS Planned sale
11,524 -38.4%
385.03
US$4,969,625
11,524 -38.4% 385.03 US$4,969,625
2026-05-06 2026-05-06 PrS Proposed sale
22,162
322.99
US$28,331
22,162 322.99 US$28,331
2026-05-06 2026-05-05 S Sale
32,416 -5.0%
426.48
US$3,582,586
32,416 -5.0% 426.48 US$3,582,586
2026-05-05 2026-05-05 PrS Proposed sale
2,181
46.65
US$101,744
2,181 46.65 US$101,744
2026-04-15 2026-04-15 PlS Planned sale
1,014 -0.9%
42.61
US$43,207
1,014 -0.9% 42.61 US$43,207
2026-04-15 2026-04-15 PrS Proposed sale
1,014
42.61
US$43,207
1,014 42.61 US$43,207
2026-04-15 2026-04-14 S Sale
7,239 -5.8%
41.93
US$303,523
7,239 -5.8% 41.93 US$303,523
2026-04-15 2026-04-14 PlS Planned sale
9 -0.0%
41.07
US$370
9 -0.0% 41.07 US$370
2026-04-14 2026-04-14 PrS Proposed sale
7,239
41.93
US$303,522
7,239 41.93 US$303,522
2026-04-14 2026-04-14 PrS Proposed sale
9
41.07
US$370
9 41.07 US$370
2026-04-15 2026-04-13 S Sale
65 -0.1%
28.85
US$1,875
65 -0.1% 28.85 US$1,875
2026-04-13 2026-04-13 PrS Proposed sale
65
28.85
US$1,875
65 28.85 US$1,875
2026-02-05 2026-02-04 PlS Planned sale
110 -0.1%
32.90
US$3,619
110 -0.1% 32.90 US$3,619
2026-02-05 2026-02-04 PlS Planned sale
1,635 -1.4%
32.14
US$52,549
1,635 -1.4% 32.14 US$52,549
2026-02-04 2026-02-04 PrS Proposed sale
1,745
32.19
US$56,166
1,745 32.19 US$56,166
2026-02-03 2026-02-03 S Sale
7,242 -6.0%
32.12
US$232,613
7,242 -6.0% 32.12 US$232,613
2026-02-03 2026-02-03 PrS Proposed sale
7,242
32.12
US$232,616
7,242 32.12 US$232,616
2026-02-03 2026-02-03 S Sale
7,242 -6.0%
32.12
US$232,613
7,242 -6.0% 32.12 US$232,613
2025-12-03 2025-12-01 PlS Planned sale
20,000 -17.8%
35.01
US$700,202
20,000 -17.8% 35.01 US$700,202
2025-12-01 2025-12-01 PrS Proposed sale
20,000
35.01
US$700,200
20,000 35.01 US$700,200
2025-09-05 2025-09-04 PlS Planned sale
119 -0.1%
19.71
US$2,345
119 -0.1% 19.71 US$2,345
2025-09-05 2025-09-03 S Sale
454 -0.5%
18.20
US$8,263
454 -0.5% 18.20 US$8,263
2025-08-28 2025-08-27 PlS Planned sale
470 -0.5%
17.31
US$8,136
470 -0.5% 17.31 US$8,136
2025-05-05 2025-05-05 PrS Proposed sale
1,784
21.05
US$37,553
1,784 21.05 US$37,553
2025-05-05 2025-05-05 S Sale
1,784 -1.9%
21.05
US$37,553
1,784 -1.9% 21.05 US$37,553
2025-04-14 2025-04-11 S Sale
48 -0.1%
13.14
US$631
48 -0.1% 13.14 US$631
2025-04-11 2025-04-11 PrS Proposed sale
48
13.14
US$631
48 13.14 US$631
2025-02-04 2025-02-03 S Sale
5,192 -5.5%
20.12
US$104,463
5,192 -5.5% 20.12 US$104,463
2025-02-03 2025-02-03 PrS Proposed sale
5,192
20.12
US$104,457
5,192 20.12 US$104,457
2025-01-23 2025-01-22 S Sale
865 -1.2%
18.94
US$16,384
865 -1.2% 18.94 US$16,384
2024-09-09 2024-09-09 S Sale
2,490 -3.2%
11.52
US$28,685
2,490 -3.2% 11.52 US$28,685
2024-09-05 2024-09-04 S Sale
514 -0.7%
9.51
US$4,888
514 -0.7% 9.51 US$4,888
2024-04-12 2024-04-11 S Sale
54 -0.1%
6.74
US$364
54 -0.1% 6.74 US$364
2024-02-02 2024-02-01 S Sale
3,818 -5.1%
8.53
US$32,573
3,818 -5.1% 8.53 US$32,573
2024-01-25 2024-01-23 S Sale
853 -1.7%
9.07
US$7,735
853 -1.7% 9.07 US$7,735
2023-09-05 2023-09-05 S Sale
457 -0.9%
14.71
US$6,723
457 -0.9% 14.71 US$6,723
2023-05-12 2023-05-10 S Sale
455 -0.9%
16.59
US$7,548
455 -0.9% 16.59 US$7,548
2023-04-13 2023-04-11 S Sale
47 -0.1%
21.49
US$1,010
47 -0.1% 21.49 US$1,010
2023-02-02 2023-02-01 S Sale
1,588 -3.0%
21.75
US$34,542
1,588 -3.0% 21.75 US$34,542
2023-01-26 2023-01-24 S Sale
852 -2.5%
21.90
US$18,663
852 -2.5% 21.90 US$18,663